(Q44541890)

4 December 2017

title

The prevalence of neurosensorial hearing loss among cystic fibrosis patients from Hospital de Clínicas de Porto Alegre (English)

1 reference

4 December 2017

0 references

1 reference

Otavio Bejzman Piltcher

1

1 reference

4 December 2017

Vanessa Niemiec Teixeira

2

1 reference

4 December 2017

Marcelo Wierzynski de Oliveira

3

1 reference

4 December 2017

Isabella Scattolin

4

1 reference

4 December 2017

Simão Levin Piltcher

5

1 reference

4 December 2017

publication date

1 September 2003

1 reference

International Journal of Pediatric Otorhinolaryngology

4 December 2017

published in

1 reference

4 December 2017

volume

67

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

939-941

1 reference

Cystic fibrosis--an otolaryngologic perspective

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

1 reference

7 January 2021

Management of pulmonary disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

The diagnosis of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

Epidemiology, pathophysiology and etiology of sinusitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

Aminoglycoside induced ototoxicity in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

Effects of chronic tobramycin treatment on distortion product otoacoustic emissions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

Assessment of potential ototoxicity following high-dose nebulized tobramycin in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

Sensorineural hearing loss among sickle cell disease patients from southern Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5876%2803%2900135-6

7 January 2021

10.1016/S0165-5876(03)00135-6

Identifiers

DOI

1 reference

4 December 2017

1 reference